Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
XCF Global Insider EEME Energy SPV I LLC Buys $142M of Stock
EEME Energy SPV I LLC bought 119,397,858 shares of XCF Global, Inc. at $1.19 a share, worth $142M in total on Oct 16, 2026. Shares held after the trade: 228,897,418 (+109.0%).
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.19M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $540.48 to $551.50 a share (average $546.65) in 12 transactions, worth $5.19M in total on Oct 15, 2026. Shares held after the trade: 324,443 (-0.0%).
WAFD Inc. reported its fiscal year and fourth quarter 2026 results, highlighted by a 22% increase in annual earnings per share to $3.21. The company saw significant improvements in asset quality with non-performing assets and delinquencies both decreasing by 37% since the prior quarter, despite a $36 million charge-off related to a large classified loan resolution.
Term
FY2026
“We are pleased to report the results for our fiscal year end 2026, including increasing earnings per share by 22%, increasing our transaction deposit balances by 4.6%, and growing our active loan segments by 7.9% along with seeing significant improvements in asset quality measures. Specifically, both non-performing assets and delinquencies decreased by 37% since the June 30th quarter end. Asset quality measures improved primarily through the resolution of a large previously classified loan during the quarter resulting in a $36 million charge-off. Our balance sheet strength and resiliency were demonstrated this quarter, allowing us to handle the classified loan, while still delivering meaningful improvement in earnings to shareholders. In spite of the recent surge in interest rates to their highest level in the last twenty years, with the 10 year bond at levels above 5.20%, WaFd is well positioned to benefit from rising rates as our assets are expected to reprice more quickly than our liabilities resulting in expansion of our margin over the short term.”
United Therapeutics EVP & General Counsel Paul A. Mahon Sells $4.52M of Stock
Paul A. Mahon, EVP & General Counsel, sold 8,300 shares of United Therapeutics Corp at $541.64 to $546.56 a share (average $544.30) in 6 transactions, worth $4.52M in total on Oct 15, 2026. Shares held after the trade: 45,172 (-1.6%).
Mobia Medical, Inc. appointed Myriam J. Curet, M.D., to its nominating and corporate governance committee, effective October 15, 2026. This filing is an amendment to a previous 8-K to finalize her committee assignment following her earlier election to the Board of Directors.
Veeva Systems SVP, Gen. Counsel, Secretary Jonathan Faddis Sells $1.56M of Stock
Jonathan Faddis, SVP, Gen. Counsel, Secretary, sold 5,198 shares of Veeva Systems Inc at $298.19 to $300.14 a share (average $299.72) in 3 transactions, worth $1.56M in total on Oct 14, 2026. Shares held after the trade: 4,130 (-14.6%).
Lucid Diagnostics Inc. received a deficiency notice from Nasdaq on October 12, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days. The company has 180 calendar days, until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days.
Acurx Pharmaceuticals held its Annual Meeting of Stockholders on October 16, 2026, where shareholders elected David P. Luci and Jack H. Dean as Class II directors for three-year terms. Additionally, stockholders ratified the appointment of CohnReznick LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Mobia Medical, Inc. announced that the Board of Directors appointed Dr. Reza Zadno to its audit committee, effective October 15, 2026. Dr. Zadno, who was previously elected to the Board, will also continue to serve on the company's compensation committee.
Alliance Entertainment Holding Executive Compensation
Alliance Entertainment Holding Corporation increased the annual base salary of its Chief Financial Officer, Amanda Gnecco, to $350,000 from $247,200. The company also established a prorated annual bonus target of $81,075 for the fiscal year ending June 30, 2027, to reflect the mid-year salary adjustment.
Bayview Acquisition Corp deposited $50,000 into its trust account to extend the deadline for completing its initial business combination by one month. The extension moves the deadline from October 19, 2026, to November 19, 2026, and represents the fifth of six permitted monthly extensions.
Polar Power, Inc. held its 2026 Annual Meeting of Stockholders on October 14, 2026, where shareholders elected six directors and ratified Weinberg & Company, P.A. as the independent auditor. Shareholders also approved a potential reverse stock split at a ratio between 1-for-3 and 1-for-20 and authorized the potential issuance of shares exceeding 19.99% of outstanding stock for future financing transactions.
Arrive AI Inc. reported that its independent auditor, Stephano Slack LLC, resigned effective October 13, 2026, and was replaced by M&K CPAS, PLLC. The company disclosed a persistent material weakness in internal controls related to the valuation of embedded derivatives in hybrid financial instruments, which previously led to financial restatements in April 2026.
Pepsico Debt Financing Update with Deutsche Bank AG, London Branch and HSBC Bank plc
PepsiCo, Inc. completed an offering of €500 million in 3.750% Senior Notes due 2029 and €500 million in 4.250% Senior Notes due 2035. The company received net proceeds of approximately €994 million, which will be used for general corporate purposes and the repayment of commercial paper.
Goldentree Asset Management LP bought 137,000 shares of Keenova Therapeutics plc at $90.00 a share, worth $12.3M in total on Oct 14, 2026. Shares held after the trade: 8,579,827 (+1.6%).
Bank of Marin Bancorp announced that Brandi Campbell, Executive Vice President and Head of Retail Banking, has mutually agreed to terminate her employment effective October 16, 2026. Under a separation agreement, she will receive three months of lump-sum pay and nine months of COBRA premium reimbursements in exchange for a release of claims.
Envoy Medical stockholders approved an amendment to the certificate of incorporation to authorize a reverse stock split of Class A Common Stock at a ratio between 1-for-5 and 1-for-25. The Board of Directors has the discretion to effect the split at any time on or before December 31, 2026.
Health In Tech received two deficiency notices from Nasdaq regarding its failure to maintain a majority of independent directors on its board and for its stock price falling below the $1.00 minimum bid requirement for 30 consecutive days. The company has until April 12, 2027, to regain compliance with the bid price rule and until its next annual meeting to resolve the board independence issue. Management expects to regain compliance following the election of a new independent director at the annual meeting scheduled for November 10, 2026.
Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $20.5M of Stock
Nippon Life Insurance Co, 10% Owner, bought 602,103 shares of Corebridge Financial, Inc. at $34.03 a share, worth $20.5M in total on Oct 14, 2026. Shares held after the trade: 128,990,035 (+0.5%).
The NXG Cushing Midstream Energy Fund announced it will change its name to The NXG Cushing Energy Infrastructure Fund effective December 18, 2026. The Fund is also broadening its investment policy to focus on energy infrastructure investments rather than strictly midstream energy investments, allowing for exposure to power, utility, and renewable energy assets.
Rekor Systems held its 2026 Annual Meeting of Stockholders on October 16, 2026, after multiple adjournments to achieve a quorum. Shareholders elected six directors to serve until 2027, ratified CBIZ CPAs P.C. as the independent auditor for fiscal year 2026, and approved executive compensation on an advisory basis.
Marvell Technology Chairman of the Board and CEO Matthew J. Murphy Sells $1.77M of Stock
Matthew J. Murphy, Chairman of the Board and CEO, sold 7,500 shares of Marvell Technology, Inc. at $235.47 a share, worth $1.77M in total on Oct 15, 2026. Shares held after the trade: 768,186 (-1.0%).
Procter & Gamble reported the results of its 2026 Annual Meeting of Shareholders held on October 13, 2026. Shareholders elected 12 directors to one-year terms, ratified Deloitte & Touche LLP as the independent auditor, and approved executive compensation in an advisory 'Say on Pay' vote.
Hippo Holdings CEO Spinnaker Torben Ostergaard Sells $41K of Stock
Torben Ostergaard, CEO Spinnaker, sold 1,169 shares of Hippo Holdings Inc. at $35.03 a share, worth $41K in total on Oct 15, 2026. Shares held after the trade: 60,655 (-1.9%).
Verisk Analytics CFO Elizabeth Mann Sells $73.9K of Stock
Elizabeth Mann, CFO, sold 400 shares of Verisk Analytics, Inc. at $184.85 a share, worth $73.9K in total on Oct 15, 2026. Shares held after the trade: 17,584 (-2.2%).
TransDigm Group Co-COO Joel Reiss Sells $4.62M of Stock
Joel Reiss, Co-COO, sold 4,100 shares of TransDigm Group INC at $1,112.27 to $1,135.95 a share (average $1,128.04) in 21 transactions, worth $4.62M in total on Oct 15, 2026. Shares held after the trade: 3,600 (-10.8%).
The Bank of New York Mellon Corporation announced that Vikram Malhotra, who was previously elected to the Board of Directors effective October 1, 2026, has been appointed to the Board's Risk Committee and Finance Committee. This filing serves as an amendment to a previous 8-K to finalize his committee assignments.
Paylocity Holding Executive Chairman Steven R. Beauchamp Sells $2.48M of Stock
Steven R. Beauchamp, Executive Chairman, sold 15,000 shares of Paylocity Holding Corp at $161.38 to $165.96 a share (average $165.22) in 5 transactions, worth $2.48M in total on Oct 15, 2026. Shares held after the trade: 1,243,389 (-0.5%).
Paylocity Holding Insider Steven I. Sarowitz Sells $2.93M of Stock
Steven I. Sarowitz sold 17,694 shares of Paylocity Holding Corp at $165.59 to $166.21 a share (average $165.80) in 2 transactions, worth $2.93M in total on Oct 15, 2026. Shares held after the trade: 4,430,701 (-0.1%).
Gilead Sciences CFO Andrew D. Dickinson Sells $469K of Stock
Andrew D. Dickinson, CFO, sold 3,000 shares of Gilead Sciences, Inc. at $156.22 a share, worth $469K in total on Oct 15, 2026. Shares held after the trade: 161,096 (-1.8%).